Exact Sciences Stock Buy Hold or Sell Recommendation
| EXAS Stock | USD 63.24 0.29 0.46% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding EXACT Sciences is 'Cautious Hold'. Macroaxis provides EXACT Sciences buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding EXAS positions. The advice algorithm takes into account all of EXACT Sciences' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting EXACT Sciences' buy or sell advice are summarized below:
Real Value 74.27 | Target Price 106.38 | Hype Value 63.18 | Market Value 63.24 | Naive Value 55.65 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell EXACT Sciences given historical horizon and risk tolerance towards EXACT Sciences. When Macroaxis issues a 'buy' or 'sell' recommendation for EXACT Sciences, the advice is generated through an automated system that utilizes algorithms and statistical models.
EXACT |
Execute EXACT Sciences Buy or Sell Advice
The EXACT recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on EXACT Sciences. Macroaxis does not own or have any residual interests in EXACT Sciences or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute EXACT Sciences' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Responds to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
EXACT Sciences Trading Alerts and Improvement Suggestions
| EXACT Sciences had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 2.5 B. Net Loss for the year was (204.15 M) with profit before overhead, payroll, taxes, and interest of 1.51 B. | |
| EXACT Sciences has a poor financial position based on the latest SEC disclosures | |
| Over 87.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from zacks.com: Quest Diagnostics Q1 Earnings Top Estimates, Margins Down |
EXACT Sciences Returns Distribution Density
The distribution of EXACT Sciences' historical returns is an attempt to chart the uncertainty of EXACT Sciences' future price movements. The chart of the probability distribution of EXACT Sciences daily returns describes the distribution of returns around its average expected value. We use EXACT Sciences price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of EXACT Sciences returns is essential to provide solid investment advice for EXACT Sciences.
| Mean Return | -0.01 | Value At Risk | -4.25 | Potential Upside | 4.44 | Standard Deviation | 2.92 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of EXACT Sciences historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
EXACT Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as EXACT Sciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading EXACT Sciences backward and forwards among themselves. EXACT Sciences' institutional investor refers to the entity that pools money to purchase EXACT Sciences' securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Ameriprise Financial Inc | 2023-12-31 | 2.5 M | Amvescap Plc. | 2023-12-31 | 2.2 M | Sumitomo Mitsui Trust Holdings Inc | 2024-03-31 | 2 M | Allspring Global Investments Holdings, Llc | 2023-12-31 | 1.9 M | Goldman Sachs Group Inc | 2023-12-31 | 1.8 M | Nikko Asset Management Americas Inc | 2023-12-31 | 1.8 M | Citadel Advisors Llc | 2023-09-30 | 1.7 M | Norges Bank | 2023-12-31 | 1.6 M | Ensign Peak Advisors Inc | 2023-12-31 | 1.5 M | Vanguard Group Inc | 2023-12-31 | 17.6 M | Jpmorgan Chase & Co | 2023-12-31 | 16.7 M |
EXACT Sciences Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 17.1M | 1.3B | (1.2B) | (73.0M) | 366.9M | 385.2M | |
| Free Cash Flow | (286.8M) | 72.1M | (238.0M) | (438.0M) | 31.9M | 33.5M | |
| Depreciation | 50.2M | 163.4M | 180.3M | 197.6M | 206.6M | 216.9M | |
| Other Non Cash Items | 48.9M | 721.3M | 202.0M | 33.8M | (76.4M) | (72.5M) | |
| Capital Expenditures | 171.8M | 64.4M | 135.8M | 214.5M | 124.2M | 130.4M | |
| Net Income | (84.0M) | (848.5M) | (595.6M) | (623.5M) | (204.1M) | (214.4M) | |
| End Period Cash Flow | 177.5M | 1.5B | 315.8M | 242.8M | 609.7M | 640.2M | |
| Change To Inventory | (19.0M) | (30.3M) | (9.2M) | (13.2M) | (7.7M) | (8.1M) | |
| Investments | 1.0B | (219.2M) | (387.8M) | 278.8M | 49.7M | 52.2M | |
| Dividends Paid | 17.2M | 18.4M | 37.5M | 169.5M | 194.9M | 108.4M | |
| Change To Netincome | 106.5M | 777.6M | 195.3M | 181.3M | 208.5M | 131.1M | |
| Net Borrowings | 236.4M | 975.5M | (23.7M) | 50M | 57.5M | 54.6M | |
| Change Receivables | (27.9M) | (100.5M) | 25.2M | 61.1M | 70.3M | 73.8M |
EXACT Sciences Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to EXACT Sciences or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that EXACT Sciences' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a EXACT stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.14 | |
β | Beta against NYSE Composite | 1.38 | |
σ | Overall volatility | 3.00 | |
Ir | Information ratio | -0.04 |
EXACT Sciences Volatility Alert
EXACT Sciences exhibits very low volatility with skewness of 0.07 and kurtosis of 1.19. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure EXACT Sciences' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact EXACT Sciences' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.EXACT Sciences Fundamentals Vs Peers
Comparing EXACT Sciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze EXACT Sciences' direct or indirect competition across all of the common fundamentals between EXACT Sciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as EXACT Sciences or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of EXACT Sciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing EXACT Sciences by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare EXACT Sciences to competition |
| Fundamentals | EXACT Sciences | Peer Average |
| Return On Equity | -0.066 | -0.31 |
| Return On Asset | -0.0304 | -0.14 |
| Profit Margin | (0.08) % | (1.27) % |
| Operating Margin | (0.12) % | (5.51) % |
| Current Valuation | 13.12 B | 16.62 B |
| Shares Outstanding | 181.53 M | 571.82 M |
| Shares Owned By Insiders | 1.00 % | 10.09 % |
| Shares Owned By Institutions | 87.00 % | 39.21 % |
| Number Of Shares Shorted | 6.34 M | 4.71 M |
| Price To Earning | (38.17) X | 28.72 X |
| Price To Book | 4.12 X | 9.51 X |
| Price To Sales | 5.18 X | 11.42 X |
| Revenue | 2.5 B | 9.43 B |
| Gross Profit | 1.51 B | 27.38 B |
| EBITDA | (13.13 M) | 3.9 B |
| Net Income | (204.15 M) | 570.98 M |
| Cash And Equivalents | 728.04 M | 2.7 B |
| Cash Per Share | 4.11 X | 5.01 X |
| Total Debt | 2.55 B | 5.32 B |
| Debt To Equity | 0.77 % | 48.70 % |
| Current Ratio | 2.48 X | 2.16 X |
| Book Value Per Share | 17.34 X | 1.93 K |
| Cash Flow From Operations | 156.12 M | 971.22 M |
| Short Ratio | 3.00 X | 4.00 X |
| Earnings Per Share | (1.13) X | 3.12 X |
| Price To Earnings To Growth | (1.07) X | 4.89 X |
| Target Price | 90.76 | |
| Number Of Employees | 6.5 K | 18.84 K |
| Beta | 1.23 | -0.15 |
| Market Capitalization | 11.53 B | 19.03 B |
| Total Asset | 6.47 B | 29.47 B |
| Retained Earnings | (3.47 B) | 9.33 B |
| Working Capital | 679.67 M | 1.48 B |
Note: Acquisition by Jeffrey Elliott of 5701 shares of EXACT Sciences subject to Rule 16b-3 [view details]
EXACT Sciences Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as EXACT . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About EXACT Sciences Buy or Sell Advice
When is the right time to buy or sell EXACT Sciences? Buying financial instruments such as EXACT Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2021 | 2022 | 2023 | 2024 (projected) | Total Stockholder Equity | 3.4B | 3.0B | 3.1B | 3.3B | Total Assets | 6.7B | 6.2B | 6.5B | 6.8B |
Use Investing Ideas to Build Portfolios
In addition to having EXACT Sciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Compulsion Thematic Idea Now
Compulsion
Companies involved in research, development, and manufacturing of products with compulsion characteristics such as cigarettes, addictive drugs and alcohol. The Compulsion theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Compulsion Theme or any other thematic opportunities.
| View All Next | Launch |
Check out EXACT Sciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy EXACT Stock please use our How to Invest in EXACT Sciences guide.Note that the EXACT Sciences information on this page should be used as a complementary analysis to other EXACT Sciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Complementary Tools for EXACT Stock analysis
When running EXACT Sciences' price analysis, check to measure EXACT Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EXACT Sciences is operating at the current time. Most of EXACT Sciences' value examination focuses on studying past and present price action to predict the probability of EXACT Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EXACT Sciences' price. Additionally, you may evaluate how the addition of EXACT Sciences to your portfolios can decrease your overall portfolio volatility.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |
Is EXACT Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EXACT Sciences. If investors know EXACT will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EXACT Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.13) | Revenue Per Share 13.876 | Quarterly Revenue Growth 0.17 | Return On Assets (0.03) | Return On Equity (0.07) |
The market value of EXACT Sciences is measured differently than its book value, which is the value of EXACT that is recorded on the company's balance sheet. Investors also form their own opinion of EXACT Sciences' value that differs from its market value or its book value, called intrinsic value, which is EXACT Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EXACT Sciences' market value can be influenced by many factors that don't directly affect EXACT Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EXACT Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if EXACT Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EXACT Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.